Clinical Trial: PCSK9 Randomized Evaluation for Contrast-Induced Nephropathy Strategy in Elective PCI (PRECISE-CIN) (China)

China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'PCSK9 Randomized Evaluation for Contrast-Induced Nephropathy Strategy in Elective PCI (PRECISE-CIN)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133349

Registration Time: 2026/09/24

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344559

Published by HT Digital Content Services with permission from Health Daily Digest....